APTIVUS

Identification of Aptivus

No description

Google image searchProduct monograph

Active ingredient

tipranavir, 250 MG

DIN: 02273322

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: BOEHRINGER INGELHEIM (CANADA) LTD LTEE

Date: 01-DEC-2005

ATC:

• J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
• J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
• J05AE — Protease inhibitors (ATC, ATC/DDD)
• J05AE09 — TIPRANAVIR (ATC/DDD)

Reference brand drug: Aptivus

External Links for Aptivus

Search on Google

• Aptivus side effects
• Aptivus dosage
• tipranavir side effects
• tipranavir dosage

Boehringer Ingelheim (Canada) Ltd Ltee

Go to Boehringer Ingelheim website to see drug product details. Sometimes you can find aptivus photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.